-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
PMV Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2019 to Q3 2024.
- PMV Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $2.22M, a 33.1% decline year-over-year.
- PMV Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $10.6M, a 15.2% decline year-over-year.
- PMV Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $12.4M, a 21.4% increase from 2022.
- PMV Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $10.2M, a 90.9% increase from 2021.
- PMV Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $5.34M, a 176% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)